http://jcps.bjmu.edu.cn

• Reviews • Previous Articles     Next Articles

Discovery and early evaluation of new chemical entities

Jing Deng, Fei Zhao, Jian Li, Hong Liu, Hualiang Jiang*   

  1. 1. Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
    2. Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
  • Received:2012-05-23 Revised:2012-07-28 Online:2012-09-15 Published:2012-09-15
  • Contact: Hualiang Jiang*

Abstract:

Drug discovery is a costly and time-consuming process, with very few novel molecular entities approved for clinical use today. With the advancement of computational chemistry, integrated X-ray crystallography and nuclear magnetic resonance spectroscopy technology, more and more potential therapeutic agents for the treatment of human diseases are discovered. Furthermore, multiple medicinal chemistry approaches have been developed in support of early drug discovery. However, there is still much can be done in the early phase of drug discovery to improve the chances of success of a drug candidate. This paper reviews the discovery and evaluation of new chemical entities in the early stages of drug development.

Key words: Drug discovery, Early drug evaluation, ADMET

CLC Number: 

Supporting: